Akito Hata

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Cancer medicine

Advances in therapy

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Akito Hata, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba
A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients. Advances in therapy 41 (9) (2024)
Akito Hata, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba
A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients. Advances in therapy 41 (9) (2024)
Akito Hata, Simon Fifer, Kazuo Hasegawa, Emiko Ando, Mami Kasahara-Kiritani, Michiko Takahashi, Robyn Ordman, Lili Toh, Akira Inoue
Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor-mutant non-small cell lung cancer. Cancer medicine 13 (1) (2024)
Akito Hata, Simon Fifer, Kazuo Hasegawa, Emiko Ando, Mami Kasahara-Kiritani, Michiko Takahashi, Robyn Ordman, Lili Toh, Akira Inoue
Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor-mutant non-small cell lung cancer. Cancer medicine (2024)
Akito Hata, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba
A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients. Advances in therapy 41 (9) (2024)
Akito Hata, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba
A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients. Advances in therapy (2024)
Akito Hata, Simon Fifer, Kazuo Hasegawa, Emiko Ando, Mami Kasahara-Kiritani, Michiko Takahashi, Robyn Ordman, Lili Toh, Akira Inoue
Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor-mutant non-small cell lung cancer. Cancer medicine (2024)
Akito Hata, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba
A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients. Advances in therapy 41 (9) (2024)
Akito Hata, Simon Fifer, Kazuo Hasegawa, Emiko Ando, Mami Kasahara-Kiritani, Michiko Takahashi, Robyn Ordman, Lili Toh, Akira Inoue
Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor-mutant non-small cell lung cancer. Cancer medicine (2024)
Takehiro Umemura, Hirotsugu Kenmotsu, Daisuke Hazama, Shunsuke Teraoka, Hiroshi Kobe, Kazuhiko Nakagawa, Teppei Yamaguchi, Takeshi Masuda, Toshihide Yokoyama, Isamu Okamoto, Koji Haratani, Daisuke Hayakawa, Masahide Oki, Shinnosuke Takemoto, Tomohiro Ozaki, Yusaku Akashi, Akito Hata, Hiroya Hashimoto, Nobuyuki Yamamoto, Kazuhiko Nakagawa
Liquid biopsy detects genomic drivers in NSCLC without EGFR mutations by single-plex testing: WJOG13620L. Cancer medicine (2023)
Akito Hata, Isamu Okamoto, Naoki Inui, Morihito Okada, Masahiro Morise, Kohei Akiyoshi, Masayuki Takeda, Yasutaka Watanabe, Shunichi Sugawara, Naofumi Shinagawa, Kaoru Kubota, Toshiaki Saeki, Tomohide Tamura
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)